Android
Nokia
Windows
Published on Mon, Nov 19, 2007 at 19:05 | Source : Moneycontrol.com
Updated at Mon, Nov 19, 2007 at 19:20
ALSO READ
Novartis India
BSE | NSE 01/01/70
The polymorph patent of Novartis ' drug Gleevec has been challenged in the US, reports CNBC-TV18.
Gleevec is Novartis' anti-cancer drug. Novartis has confirmed the challenge to polymorph patent of Gleevec.
PREVIOUS STORY
Buy TVS Motor; target Rs 43: Dolat Capital
NEXT STORY
How credit card companies are making a comeback
KKR in way of CSK's hat-trick of IPL titles
Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)
May 26 2012, 16:36
Mood downbeat but time to buy good values now: Citi`s Vaish
- in FII View
May 25 2012, 22:26
NHPC posts profit amid capacity addition, delay woes
- in Results Boardroom
May 27 2012, 11:52 | Source: CNBC-TV18
Expect to maintain EBIDTA margin ahead: Wockhardt
May 27 2012, 11:00 | Source: CNBC-TV18
e-commerce market in India: What's in store?
Subscribe to
Moneycontrol Newsletters
Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!
The polymorph patent of 
